ERBB2 and metastatic malignant neoplasm in the lymph nodes: In a large cohort of patients with GC, HER2 overexpression was reported as 11.8% of GC and was significantly related to aging, intestinal histology, clinical stages, venous invasion, and frequent lymph node metastasis [19].